Plasma markers such as Ang-2, sICAM-1, sVCAM-1, vWF, TNFα, IFNγ, and CXCL10 offer significant potential for early risk stratification and prognosis in CM [6,13,14,28]. Here, ANGPT2 is linked to cutaneous mastocytosis.